BioStem Technologies, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 1.12 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 20.81M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a human connective tissue matrix compromised of amniotic tissue intended for wound covering; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.
Details
| Name | BioStem Technologies, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 73 |
| Founded | 2006 |
| Ceo | Jason Matuszewski |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US0906842002 |
| Cusip | 090684200 |
| Cik | 0001658678 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Jason V. Matuszewski | Chief Executive Officer, President, Secretary and Chairman |
| Brandon Poe | Chief Financial Officer |
| Andrew Van Vurst CTBS | Chief Operating Officer and Director |
| Michael A. Fortunato C.P.A. | Chief Accounting Officer |
| Noah Agron | Vice President of Corporate Finance and Strategy |
| Katherine Gorrell | Chief Legal and Compliance Officer |
| Jeff Humke | Vice President of Human Resources |
| Dr. David M. Woynarowski | Chief Medical Officer |
| Larry Jones | Chief Revenue Officer |
| Dr. Irmgard Huber M.D. | International Medical Advisor and Interim Chief Medical Officer |
Contact
| Address | 4901 Northwest 17th Way, Suite 606, Fort Lauderdale, Florida 33309, United States |
| Phone | 954 380 8342 |
| Website | https://biostemtechnologies.com |